BOLT Bolt Biotherapeutics Inc. Net earnings per share growth forecast for next year
The consensus EPS forecast for the coming year, as seen on the GURU.Markets chart, highlights the potential of the Bolt Biotherapeutics (BOLT) platform in combating metastases. The -10.60 metric determines the status of the expected profit parameter while management strives to implement new oncological therapy standards. Automated dispensers and predictive data analysis software in the company's laboratories complement the technology stack.
Metric breakdowns and analytics for Bolt Biotherapeutics, Inc. (BOLT)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Debt to Equity Bolt Biotherapeutics|BOLT - Long-Term Liabilities to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|BOLT - Company Debts|Debt to Book Value Bolt Biotherapeutics|BOLT - Amount of Long-Term Liabilities|Company Current Liabilities Bolt Biotherapeutics|Quick Ratio boltbio.com
- earnings and valuation multiples information:
BOLT - Company Net Income|Projected Future Earnings Bolt Biotherapeutics|BOLT - Business Payback Period|Future Price to Earnings Bolt Biotherapeutics Inc.|BOLT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Bolt Biotherapeutics|BOLT - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Bolt Biotherapeutics|BOLT - Earnings per share for the trailing year|Quarterly EPS earnings growth boltbio.com|BOLT - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Bolt Biotherapeutics
- total revenue and sales volume data:
Summary company analysis:Bolt Biotherapeutics
Bolt Biotherapeutics, as a developer of immuno-oncology drugs, faces high R&D expenditure pressure in the absence of revenue. This metric measures the consensus earnings per share (EPS) forecast, reflecting the business's ability to optimize costs while scaling clinical trials. By analyzing the expected EPS trend for the next period, the investor assesses the risk of inflated expectations regarding the actual speed of pipeline commercialization.
Direct competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|GRFS: Net earnings per share growth forecast for next year|Adaptive Biotechnologies (ADPT) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year celldex.com (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharmaceuticals Inc.|Net earnings per share growth forecast for next year BCRX|Expected earnings per share growth for next year VERA (Vera Pharma)|Projected earnings per share increase next year DNTH|Pharvaris N.V. - Expected earnings per share growth for next year|Expected earnings per share trend next year ABCL|Tourmaline Bio - Earnings growth forecast for next year|PGEN: Net earnings per share growth forecast for next year|PHAR: Earnings growth forecast for next year|NKTR - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Upstream Bio Inc|Expected net earnings per share growth next year zenasbio.com ZBIO|Expected earnings per share growth for next year IMNM (Immunome)|Projected earnings per share increase next year GOSS|Earnings growth forecast for next year KALV (KalVista Pharmaceuticals Inc)|Expected earnings per share trend next year SEPN|Pieris Pharmaceuticals - Earnings growth forecast for next year|Expected net earnings per share growth next year savarapharma.com|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth forecast for next year|AnaptysBio Inc - Expected earnings per share trend next year|ATXS (Astria Pharma) - Earnings growth forecast for next year|Earnings growth forecast for next year enGene Corp|Net earnings per share growth forecast for next year RAPT Therapeutics, Inc. (RAPT)|JBIO: Net earnings per share change forecast for next year|Earnings growth forecast for next year ACRS (Aclaris Therapeutics, Inc.)|Kyverna Therapeutics Inc. (KYTX) - Expected net earnings per share growth next year|TLSA: Expected earnings per share growth for next year|CABA - Earnings growth forecast for next year|VTYX (Ventyx Biosciences) - Expected earnings per share growth for next year|THTX: Projected earnings per share increase next year|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|Eledon Pharmaceuticals Inc. (ELDN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year AGEN|Expected earnings per share growth for next year Climb Bio, Inc CLYM|Net earnings per share growth forecast for next year Zura Bio Limited ZURA|Consensus forecast of earnings per share growth for next year atyrpharma.com (ATYR)|Adagene Corp - Earnings growth forecast for next year|IMA: Net earnings per share growth forecast for next year|shattucklabs.com (STTK) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Equillium (EQ)|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Net earnings per share growth forecast for next year IMUX|Expected earnings per share growth for next year ATRA (Atara Biotherapeutics)|Projected earnings per share increase next year IFRX|Net earnings per share growth forecast for next year X4 Pharma XFOR|ACET (Adicet Bio Inc.) - Net earnings per share change forecast for next year|Celularity Corp - Earnings growth forecast for next year|Expected earnings per share trend next year INMB (inmunebio.com)|BRNS: Earnings growth forecast for next year|Kezar Life Sciences Inc. (KZR) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year SAB Biotherapeutics, Inc|AKTX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Enlivex Therapeutics (ENLV)|Expected earnings per share growth for next year q32bio.com QTTB|Earnings growth forecast for next year GOVX (GeoVax)|Earnings growth forecast for next year Edesa Biotech Inc EDSA|IBIO: Expected earnings per share growth for next year|Expected earnings per share trend next year CARM (Carisma Therapeutics)|XTLB: Earnings growth forecast for next year|HCWB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aptevo Therapeutics, Inc.|Expected earnings per share growth for next year AIM ImmunoTech, Inc. (AIM)|Net earnings per share growth forecast for next year Aditxt (ADTX)|Expected earnings per share growth for next year GRI Bio Corporation GRI|XORTX Therapeutics Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year reshapelifesciences.com HIND|REVB - Net earnings per share growth forecast for next year|INDP (Indaptus Therapeutics Inc) - Projected earnings per share growth rate for next year|SCNI: Earnings growth forecast for next year|Expected net earnings per share growth next year CalciMedica (CALI)|AFMD (Affimed NV) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year ALLK|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGMS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year iTeos ITOS|Ocean Biomedical Corp - Net earnings per share growth forecast for next year|TCBP: Expected earnings per share growth for next year|thirdharmonicbio.com - Projected earnings per share increase next year
